Front Page News

Genentech Releases Winter SMA Community Update Letter

January 28, 2026
Posted in , ,

Genentech recently released an update on their continued collaboration with the SMA community and Evrysdi® tablet updates. They will continue to provide timely updates as […]

All 2026 Walk-n-Roll Events Are Open

January 27, 2026
Posted in , ,

Cure SMA warmly invites you to join us at one of our 2026 Walk-n-Roll events-where community meets impact! This year, you can register and start […]

Cure SMA Advocacy Highlights of 2025

January 6, 2026
Posted in ,

Thank you to the individuals with spinal muscular atrophy (SMA), their family members, and other supporters who helped advocate for SMA community priorities in 2025. […]

Together, We’re Changing the Story of SMA

December 11, 2025
Posted in , ,

Watch the video and see how far we’ve come and the future we’re building together.  Donate to Support the SMA Community Your support accelerates research, […]

Cure SMA Shares Updates on the Phase 10 SMA Industry Collaboration 

December 3, 2025
Posted in , ,

Earlier this year, Cure SMA launched an expanded Phase 10 of the SMA Industry Collaboration. The SMA Industry Collaboration is a multi-faceted partnership that brings together […]

Double Your Impact this Giving Tuesday!

December 2, 2025
Posted in , ,

Today is Giving Tuesday, and there’s an incredible opportunity to double your impact!   The Luke 18:1 Foundation has stepped forward with a $50,000 gift and […]

Novartis Receives FDA Approval of Itvisma for the Treatment of SMA

November 24, 2025
Posted in , ,

Novartis today announced  that it has received approval from the U.S. Food and Drug Administration (FDA) for Itvisma (onasemnogene abeparvovec-brve) to treat adults and children 2 years of age and older with […]

Scholar Rock and Cure SMA Share Update on Apitegromab and FDA Meeting 

November 14, 2025
Posted in , , ,

Read the Scholar Rock community statement here.   Scholar Rock recently held an in-person Type A meeting with the FDA on November 12 to discuss […]

Novartis Releases Fall SMA Community Update Letter

November 3, 2025
Posted in , , ,

Novartis recently released an update on their continued collaboration with the SMA community through fundraising events and community support programs, and they will continue to […]

Unlock a Future of Possibilities: Cure SMA Launches Year-End Campaign

November 3, 2025
Posted in , , ,

As 2025 starts to wind down, Cure SMA is proud to launch our year-end fundraising campaign: Unlock a Future of Possibilities. This theme represents hope, […]

Scroll to Top